Paradigm Financial Partners, LLC Edwards Lifesciences Corp Transaction History

Paradigm Financial Partners, LLC

$662 Million
Q2 2024

A detailed history of Paradigm Financial Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Paradigm Financial Partners, LLC holds 2,893 shares of EW stock, worth $189,433. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,893

Previous 2,505 15.49%

Holding current value

$189,433

Previous $239,000 11.72%

% of portfolio

0.04%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $32,708 - $36,592	388 Added 15.49%	2,893 $267,000
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $58,249 - $76,734	-803 Reduced 24.27%	2,505 $239,000
Q4 2023 Feb 05, 2024	SELL	$61.71 - $77.76 $1.34 Million - $1.69 Million	-21,765 Reduced 86.81%	3,308 $252,000
Q3 2023 Oct 12, 2023	SELL	$69.28 - $93.38 $346,884 - $467,553	-5,007 Reduced 16.65%	25,073 $1.74 Million
Q2 2023 Jul 13, 2023	SELL	$81.41 - $94.33 $58,452 - $67,728	-718 Reduced 2.33%	30,080 $2.84 Million
Q1 2023 Apr 11, 2023	BUY	$74.26 - $84.51 $75,893 - $86,369	1,022 Added 3.43%	30,798 $2.55 Million
Q4 2022 Jan 27, 2023	SELL	$68.3 - $87.44 $20,285 - $25,969	-297 Reduced 0.99%	29,776 $0
Q3 2022 Nov 09, 2022	BUY	$82.37 - $107.29 $31,712 - $41,306	385 Added 1.3%	30,073 $2.6 Million
Q2 2022 Jul 27, 2022	SELL	$86.5 - $128.27 $6,228 - $9,235	-72 Reduced 0.24%	29,688 $2.92 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $1.34 Million - $1.68 Million	-13,117 Reduced 30.59%	29,760 $3.58 Million
Q4 2021 Feb 18, 2022	SELL	$106.37 - $130.68 $9.11 Million - $11.2 Million	-85,622 Reduced 66.63%	42,877 $5.56 Million
Q4 2021 Feb 10, 2022	BUY	$106.37 - $130.68 $9.12 Million - $11.2 Million	85,692 Added 200.18%	128,499 $16.6 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $32,005 - $38,175	-311 Reduced 0.72%	42,807 $4.75 Million
Q2 2021 Aug 12, 2021	BUY	$83.84 - $104.76 $259,400 - $324,127	3,094 Added 7.73%	43,118 $4.47 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $339,818 - $391,603	4,319 Added 12.1%	40,024 $3.35 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $119,363 - $151,897	1,665 Added 4.89%	35,705 $3.19 Million
Q3 2020 Nov 10, 2020	BUY	$67.19 - $87.44 $565,135 - $735,457	8,411 Added 32.82%	34,040 $2.72 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $1.03 Million - $1.38 Million	17,935 Added 233.1%	25,629 $1.78 Million
Q1 2020 May 08, 2020	SELL	$52.41 - $81.0 $33,018 - $51,030	-630 Reduced 7.57%	7,694 $1.59 Million
Q4 2019 Jan 29, 2020	SELL	$71.7 - $82.09 $44,095 - $50,485	-615 Reduced 6.88%	8,324 $1.94 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $28,743 - $35,225	-467 Reduced 4.96%	8,939 $2.01 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $17,390 - $20,095	312 Added 3.43%	9,406 $1.74 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $7,662 - $10,248	160 Added 1.79%	9,094 $1.74 Million
Q4 2018 Feb 12, 2019	BUY	$46.41 - $56.94 $414,626 - $508,701	8,934 New	8,934 $1.37 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Financial Partners, LLC with notifications on news.

Account

Paradigm Financial Partners, LLC Edwards Lifesciences Corp Transaction History